Trial Profile
Prospective Institutional review trial to test de novo sirolimus monotherapy following antithmocyte globin induction in kidney transplant recipients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Antithymocyte globulin; Ciclosporin; Corticosteroids; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 06 Jul 2012 Planned end date 29 Nov 2005 added as reported by German Clinical Trials Register record.
- 06 Jul 2012 Status changed from not stated to discontinued as reported by German Clinical Trials Register record.
- 14 May 2012 New trial record